Omri Amirav-Drory
Listed on 4 Form D filings across 4+ issuers
· Director, Executive Officer
Associated issuers
- NFX SL Advantage I, L.P. CIK 2109603 · CA
- NFX SST Advantage I, L.P. CIK 2109068 · CA
- TwoStep Therapeutics, Inc. CIK 2015273 · CA
- ImmuneBridge Inc. CIK 1960306 · CA
Filings (4)
-
NFX SL Advantage I, L.P.D · 2026-03-03 · CA · Pooled Investment Fund$14.6Mview →
-
NFX SST Advantage I, L.P.D · 2026-02-26 · CA · Pooled Investment Fund$4.1Mview →
-
TwoStep Therapeutics, Inc.D · 2026-01-20 · CA · Other$62.2Mview →
-
ImmuneBridge Inc.D · 2025-04-02 · CA · Biotechnology$7.1Mview →